Response evaluations in non-small cell lung cancer patients undergoing immunotherapy: a comparative analysis of RECIST 1.1, iRECIST, and imRECIST criteria.

Shih YJ, Chen JH, Yeh LR, Lin CY, Huang SC, Yang CY

Open source

DOI
10.1007/s12032-025-03115-3
Published
2025 Nov 10
Container
Medical oncology (Northwood, London, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12032-025-03115-3,
  title = {Response evaluations in non-small cell lung cancer patients undergoing immunotherapy: a comparative analysis of RECIST 1.1, iRECIST, and imRECIST criteria.},
  author = {Shih YJ and Chen JH and Yeh LR and Lin CY and Huang SC and Yang CY},
  year = {2025},
  journal = {Medical oncology (Northwood, London, England)},
  doi = {10.1007/s12032-025-03115-3},
  url = {https://doi.org/10.1007/s12032-025-03115-3}
}

RIS

TY  - JOUR
TI  - Response evaluations in non-small cell lung cancer patients undergoing immunotherapy: a comparative analysis of RECIST 1.1, iRECIST, and imRECIST criteria.
AU  - Shih YJ
AU  - Chen JH
AU  - Yeh LR
AU  - Lin CY
AU  - Huang SC
AU  - Yang CY
PY  - 2025
JO  - Medical oncology (Northwood, London, England)
DO  - 10.1007/s12032-025-03115-3
UR  - https://doi.org/10.1007/s12032-025-03115-3
ER  - 

APA

YJ, S., JH, C., LR, Y., CY, L., SC, H., & CY, Y. (2025). Response evaluations in non-small cell lung cancer patients undergoing immunotherapy: a comparative analysis of RECIST 1.1, iRECIST, and imRECIST criteria.. Medical oncology (Northwood, London, England). https://doi.org/10.1007/s12032-025-03115-3

Source records